Skip to main content
Caplight Logo









Alcolase

Alcolase

Private
CopenhagenHealthcare & Life Scienceshttps://www.alcolase.com/

Last Round

Seed

May 17, 2026

Total Funding Raised

$1.7M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Alcolase is a biotechnology company developing an enzyme-based supplement to manage alcohol intolerance.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, D2C Brands, Precision Medicine

Business Model

B2C

Customer Profile

Hardware Sales, Hardware + Subscription

AI Layer

Non-AI

Keywords

alcohol intolerance supplementALDH2 deficiencyAsian flushenzyme supplementfacial flushingalcohol metabolismliposomal encapsulationAsian glownutraceuticalD2C supplementprecision medicinebiotechnology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Alcolase Comparables

Compare Alcolase with similar companies based on industry and business-model similarity.

Alcolase comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ZBiotics
76%
Cheers
65%
Himalaya Wellness Company
61%

Alcolase Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMay 17, 2026

Key People

Founding team and executive leadership

Mikkel Precht

CEO And Co-founder

Founding Team

Ib Christensen

COO

Executive Team

Alcolase Investors

Notable investors and investment history

Alcolase investors
InvestorRounds
Ada VenturesSeed
Delphinus Venture CapitalSeed
AntlerSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 17, 2026

    $1.5M round led by Ada Ventures, Antler, and Delphinus Venture Capital.

Alcolase Filings

Explore SEC and related filing metadata, where available.

Alcolase filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Alcolase's valuation, stock price, and market status.

Is Alcolase a public or private company?

Alcolase is a private company.

What is the current stock price of Alcolase?

Alcolase is a private company with no public stock price. No recent secondary market data is available.

How much is Alcolase worth (valuation)?

Valuation information for Alcolase is not publicly available.

Can I buy Alcolase stock?

Alcolase shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Alcolase's last funding round?

Alcolase's most recent funding round was Seed on May 17, 2026.

Who are the main investors in Alcolase?

Key investors in Alcolase include Ada Ventures, Delphinus Venture Capital, Antler AI Disrupt.

Will Alcolase IPO soon?

No public IPO plans have been announced for Alcolase.

How can I track Alcolase secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Alcolase's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCopenhagen
Employee Range10
Year Founded2020
Last FundingMay 17, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?